Breast Cancer Foundation NZ
A+7257
Early Breast Cancer clinical trials for ER+
Pending
Updated: January 20, 2022
This study looks at using a magnetic tracer verses a standard technique for sentinel node biopsy in breast cancer.
This study looks at using a magnetic tracer verses a standard technique for sentinel node biopsy in breast cancer.
Key inclusion criteria
- All women over the age of 18 undergoing sentinel node biopsy for breast cancer (invasive or ductal carcinoma, or extensive ductal carcinoma in-situ) with clinically and radiologically node-negative axillae will be eligible to participate.
Key exclusion criteria
- Exclusion criteria include patients with allergy to iron or dextran compounds, iron overload disease, pacemaker or ferrous metal-containing devices in the chest wall, pregnancy and lactation.
New Zealand
If you think you might be a candidate for this trial, use the contact details supplied, or talk to your doctor.
Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at intouch@bcf.org.nz
Similar clinical trials
For Early Breast Cancer , Screening, prevention, familial and other
Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to intouch@bcf.org.nz
Interested in a clinical trial?
Subscribe for updates & stay in the loop with new studies.